Copyright
©The Author(s) 2016.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 127-133
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.127
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.127
Relative risk estimate (95%Cl) | ||||
Coronaryartery disease | Stroke | Peripheral artery disease | Breast cancer | |
Age of patient when treatment started (yr) | ||||
20-39 | 0.48 (0.07, 3.35) | 0.68 (0.09, 5.35) | 1.57 (0.19, 12.79) | 0.83 (0.11, 6.57) |
P = 0.47 | P = 0.72 | P = 0.67 | P = 0.87 | |
40-49 | 1.14 (0.55, 2.37) | 0.98 (0.41, 2.37) | 2.25 (0.85, 5.96) | 0.66 (0.22, 1.97) |
P = 0.72 | P = 0.97 | P = 0.10 | P = 0.45 | |
50-59 | 0.83 (0.37, 1.87) | 1.18 (0.51, 2.75) | 1.63 (0.55, 4.79) | 0.87 (0.32, 2.38) |
P = 0.65 | P = 0.69 | P = 0.37 | P = 0.78 | |
60-79 | 7.7 (2.85, 20.76) | 2.19 (0.59, 8.11) | 5.01 (1.27, 19.80) | 1.67 (0.36, 7.77) |
P < 0.001 | P = 0.24 | P = 0.02 | P = 0.52 | |
Age of patient when treatment stopped (yr) | ||||
20-39 | 1.36 (0.38, 4.88) | 1.22 (0.27, 5.56) | 2.79 (0.57, 13.53) | 1.48 (0.32, 6.85) |
P = 0.64 | P = 0.80 | P = 0.20 | P = 0.61 | |
40-49 | 0.48 (0.18, 1.27) | 0.54 (0.18, 1.59) | 0.92 (0.25, 3.37) | 0.32 (0.97, 1.41) |
P = 0.50 | P = 0.26 | P = 0.90 | P = 0.13 | |
50-59 | 1.3 (0.61, 2.80) | 1.24 (0.51, 3.00) | 2.83 (1.06, 7.60) | 1.75 (0.74, 4.16) |
P = 0.50 | P = 0.64 | P = 0.04 | P = 0.20 | |
60-79 | 4.98 (2.19, 11.55) | 2.99 (1.11, 8.08) | 4.18 (1.24, 14.14) | NC |
P < 0.001 | P = 0.03 | P = 0.02 | ||
Duration of use (yr) | ||||
< 1 | 1.1 (0.24, 5.04) | NC | 3.59 (0.72, 17.75) | 1.91 (0.40, 8.98) |
P = 0.90 | P = 0.12 | P = 0.41 | ||
1-5 | 0.76 (0.31, 1.87) | 1.28 (0.53, 3.11) | 1.18 (0.32, 4.34) | 0.85 (0.28, 2.57) |
P = 0.55 | P = 0.59 | P = 0.81 | P = 0.77 | |
6-10 | 2.12 (0.90, 5.03) | 0.3 (0.04, 2.32) | 1.43 (0.31, 6.74) | 0.37 (0.40, 2.85) |
P = 0.09 | P = 0.25 | P = 0.65 | P = 0.34 | |
11-15 | 0.75 (0.26, 2.20) | 1.69 (0.65, 4.38) | 3.14 (1.04, 9.50) | 0.95 (0.27, 3.35) |
P = 0.60 | P = 0.28 | P = 0.04 | P = 0.94 | |
16-20 | 2.75 (0.93, 8.11) | 1.29 (0.28, 5.92) | NC | 0.74 (0.09, 5.84) |
P = 0.07 | P = 0.74 | P = 0.78 | ||
21-25 | 2.89 (0.73, 11.41) | 2.44 (0.50, 11.92) | 5.57 (1.07, 28.92) | 1.33 (0.16, 10.96) |
P = 0.13 | P = 0.27 | P = 0.04 | P = 0.79 | |
26+ | 1.28 (0.15, 10.97) | 1.83 (0.21, 15.80) | 10.03 (1.75, 57.58) | NC |
P = 0.82 | P = 0.58 | P = 0.01 |
- Citation: Khoo SK, Tripcony L. Variation in use of menopausal hormone treatment on risk of health outcomes. World J Obstet Gynecol 2016; 5(1): 127-133
- URL: https://www.wjgnet.com/2218-6220/full/v5/i1/127.htm
- DOI: https://dx.doi.org/10.5317/wjog.v5.i1.127